Prostate volume variation during 1.5T MR-guided adaptive stereotactic body radiotherapy (SBRT) and correlation with treatment toxicity-Reference-Cited by-同舟云学术

Prostate volume variation during 1.5T MR-guided adaptive stereotactic body radiotherapy (SBRT) and correlation with treatment toxicity

Published:2024-01 Issue: Volume:190 Page:110043
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Nicosia Luca^ORCID,Ravelli Paolo,Rigo Michele,Giaj-Levra Niccolò,Mazzola Rosario,Pastorello Edoardo,Ricchetti Francesco,Allegra Andrea Gaetano,Ruggieri Ruggero,Alongi Filippo

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference22 articles.

1. Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial;Tree;Lancet Oncol,2022

2. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial;Widmark;Lancet,2019

3. Moderate versus extreme hypofractionated radiotherapy: a toxicity comparative analysis in low- and favorable intermediate-risk prostate cancer patients;Nicosia;J Cancer Res Clin Oncol.,2019

4. The Association between Acute and Late Genitourinary and Gastrointestinal Toxicities: an analysis of the PACE B Study;Ratnakumaran;Cancers (Basel),2023

5. Acute toxicity comparison of magnetic resonance-guided adaptive versus fiducial or computed tomography-guided non-adaptive prostate stereotactic body radiotherapy: a systematic review and meta-analysis;Leeman;Cancer,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dosimetric benefit of online treatment plan adaptation in stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer;Frontiers in Oncology;2024-02-15